for worldwide rights (excluding Greater China) to BSI-045B and BSI-502, a preclinical-stage, novel bispecific antibody directed against both TSLP and IL4R ... graphics, graphs, charts, animations, and ...
BioNTech will pay Biotheus an upfront consideration of $800 million, predominantly in cash, with a small portion in American depositary shares, plus additional performance-based contingent payments of ...
NEW YORK – Marengo Therapeutics' bispecific antibody, invikafusp alfa, showed potential as treatment for certain cancer patients who have become resistant to checkpoint inhibitors in an early-phase ...
NEW YORK – Ideaya Biosciences on Monday said it is advancing a B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate, dubbed IDE034. The drug came to South San Francisco, California-based Ideaya ...
SEATTLE, WA and LUND, SWEDEN / ACCESSWIRE / November 11, 2024 / Aptevo Therapeutics (“Aptevo”) (Nasdaq:APVO) and Alligator Bioscience AB (“Alligator”) (ATORX) today announced preliminary data from the ...
He wondered whether a reagent was to blame, in particular the antibodies that scientists used to measure the amount of the protein and track its position in the cell. So, he and his colleagues ...
Wonder Dynamics, the AI-driven animation, CGI, and VFX tech company recently acquired by Autodesk, launced Wonder Animation on October 30th. The new tool brings advanced 3D animation capabilities ...
Video content above is prompted by the following: This presentation is to do a deep dive into the operationalization of bispecific antibody (BsAb) therapy in community practices. Please summarize the ...
1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. 2Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam ...
The company co-founded by Tye Sheridan launched Wonder Animation with tech that creates CG animation in 3D space via AI reconstruction. Wonder Dynamics, the artificial intelligence start-up co ...